CLINICAL_TRIALS
trial_result
· 2025-04-04
Clinical Trial Update: Obinutuzumab in Marginal Zone Lymphoma [Phase 2]
Summary
This update reports an ongoing Phase 2 clinical trial of obinutuzumab for marginal zone lymphoma, currently active and not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Christian Buske | Conditions: Marginal Zone Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING